In the Matter of Applied NeuroSolutions, Inc., Cowlitz Bancorporation, First Place Financial Corp., and Kedem Pharmaceuticals, Inc.; Order of Suspension of Trading, 35208-35209 [2014-14438]

Download as PDF 35208 Federal Register / Vol. 79, No. 118 / Thursday, June 19, 2014 / Notices language is consistent with Sections 6(b)(1) and 6(b)(5) of the Act because it promotes clarity of CHX rules by removing unnecessary and/or redundant language. This will, in turn, provide clear CHX rules for Participants to follow and the Exchange to enforce. The Exchange also believes the proposed amendment to provide the Exchange with the discretion to enable or disable certain trade adjustment functionalities will prevent Participants from utilizing adjustment functionalities that are in the process of being optimized by Exchange operations personnel (e.g., systems upgrade for verifying adjustment parameters).11 Moreover, the notice requirements will provide Participants with reasonable notice as to the availability of such adjustment options. As such, the proposed rule change is also consistent with the requirements of Sections 6(b)(1) and 6(b)(5) of the Act. B. Self-Regulatory Organization’s Statement on Burden on Competition The Exchange believes the proposal is consistent with Section 6(b)(8) of the Act 12 in that it does not impose any burden on competition that is not necessary or appropriate in furtherance of the purposes of the Act. The proposed rule change either deletes obsolete non-substantive language or provides the Exchange with operational flexibility concerning the availability of certain trade adjustment functionalities that are already codified under CHX rules. emcdonald on DSK67QTVN1PROD with NOTICES C. Self-Regulatory Organization’s Statement on Comments on the Proposed Rule Change Received From Members, Participants, or Others No written comments were either solicited or received. III. Date of Effectiveness of the Proposed Rule Change and Timing for Commission Action Pursuant to Section 19(b)(3)(A) of the Act 13 and Rule 19b–4(f) thereunder,14 CHX has designated this proposal as one that effects a change that (A) does not significantly affect the protection of investors or the public interest; (B) does not impose any significant burden on competition; and (C) by its terms, does not become operative for 30 days after the date of the filing, or such shorter time as the Commission may designate if consistent with the protection of investors and the public interest. The 11 Any substantive changes to adjustment options will only be effected through a Rule 19b–4 filing. 12 15 U.S.C. 78(f)(b)(8) [sic]. 13 15 U.S.C. 78s(b)(3)(A). 14 17 CFR 240.19b–4(f)(6). VerDate Mar<15>2010 17:25 Jun 18, 2014 Jkt 232001 Exchange has also provided the Commission written notice of its intent to file the proposed rule change, along with a brief description and text of the proposed rule change, at least five business days prior to the date of filing of the proposed rule change, or such shorter time as designated by the Commission.15 The Exchange notes that this proposal does not propose any new policies or provisions that are unique or unproven, as all changes proposed herein correct non-substantive taxonomy issues and set an operative date for functionality that has already been approved by the Commission. Given these factors, this rule filing qualifies for immediate effectiveness as a ‘‘non-controversial’’ rule change under paragraph (f)(6) of Rule 19b–4.16 At any time within 60 days of the filing of the proposed rule change, the Commission summarily may temporarily suspend such rule change if it appears to the Commission that such action is necessary or appropriate in the public interest, for the protection of investors, or otherwise in furtherance of the purposes of the Act. If the Commission takes such action, the Commission shall institute proceedings to determine whether the proposed rule should be approved or disapproved. IV. Solicitation of Comments Interested persons are invited to submit written data, views and arguments concerning the foregoing, including whether the proposal is consistent with the Act. Comments may be submitted by any of the following methods: Electronic Comments • Use the Commission’s Internet comment form (https://www.sec.gov/ rules/sro.shtml); or • Send an email to rule-comments@ sec.gov. Please include File No. SR– CHX–2014–09 on the subject line. Paper Comments • Send paper comments in triplicate to Secretary, Securities and Exchange Commission, 100 F Street NE., Washington, DC 20549. All submissions should refer to File No. SR–CHX–2014–09. This file number should be included on the subject line if email is used. To help the Commission process and review your comments more efficiently, please use only one method. The Commission will post all comments on the Commission’s Internet Web site (https://www.sec.gov/ rules/sro.shtml). Copies of the 15 17 For the Commission, by the Division of Trading and Markets, pursuant to delegated authority.17 Kevin M. O’Neill, Deputy Secretary. [FR Doc. 2014–14313 Filed 6–18–14; 8:45 am] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] In the Matter of Applied NeuroSolutions, Inc., Cowlitz Bancorporation, First Place Financial Corp., and Kedem Pharmaceuticals, Inc.; Order of Suspension of Trading June 17, 2014. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Applied NeuroSolutions, Inc. because it has not filed any periodic reports since the period ended March 31, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Cowlitz Bancorporation because it has not filed any periodic reports since the period ended March 31, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information CFR 240.19b–4(f)(6)(iii). 16 Id. PO 00000 submission, all subsequent amendments, all written statements with respect to the proposed rule change that are filed with the Commission, and all written communications relating to the proposed rule changes between the Commission and any person, other than those that may be withheld from the public in accordance with the provisions of 5 U.S.C. 552, will be available for Web site viewing and printing in the Commission’s Public Reference Room, 100 F Street NE., Washington, DC 20549 on official business days between the hours of 10:00 a.m. and 3:00 p.m. Copies of the filing also will be available for inspection and copying at the principal office of the CHX. All comments received will be posted without change; the Commission does not edit personal identifying information from submissions. You should submit only information that you wish to make available publicly. All submissions should refer to File No. SR–CHX–2014– 09 and should be submitted on or before July 10, 2014. Frm 00061 17 17 Fmt 4703 Sfmt 4703 E:\FR\FM\19JNN1.SGM CFR 200.30–3(a)(12). 19JNN1 Federal Register / Vol. 79, No. 118 / Thursday, June 19, 2014 / Notices concerning the securities of First Place Financial Corp. because it has not filed any periodic reports since the period ended June 30, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Kedem Pharmaceuticals, Inc. because it failed to include the required audited financial statements for the fiscal year ended May 31, 2012 in its Form 10–K for the period ended May 31, 2012, and it failed to file any periodic reports since it filed a Form 10–Q for the period ended November 30, 2012. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed companies. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed companies is suspended for the period from 9:30 a.m. EDT on June 17, 2014, through 11:59 p.m. EDT on June 30, 2014. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2014–14438 Filed 6–17–14; 4:15 pm] BILLING CODE 8011–01–P SECURITIES AND EXCHANGE COMMISSION [File No. 500–1] In the Matter of Crescent Banking Co., Data Storage Consulting Services, Inc., First National Bancshares, Inc., Infosmart Group, Inc., Marco Community Bancorp, Inc., and Sun River Energy, Inc. (n/k/a New River Exploration, Inc.); Order of Suspension of Trading emcdonald on DSK67QTVN1PROD with NOTICES June 17, 2014 It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Crescent Banking Co. because it has not filed any periodic reports since the period ended March 31, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Data Storage Consulting Services, Inc. because it has not filed any periodic reports since the period ended March 31, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of First National Bancshares, Inc. because it has VerDate Mar<15>2010 17:25 Jun 18, 2014 Jkt 232001 not filed any periodic reports since the period ended March 31, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Infosmart Group, Inc. because it has not filed any periodic reports since the period ended March 31, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Marco Community Bancorp, Inc. because it has not filed any periodic reports since the period ended June 30, 2010. It appears to the Securities and Exchange Commission that there is a lack of current and accurate information concerning the securities of Sun River Energy, Inc. (n/k/a New River Exploration, Inc.) because it failed to include the required audited financial statements for the fiscal year ended April 30, 2011 in its Form 10–K for the period ended April 30, 2012, and failed to file any periodic reports since it filed a Form 10–Q for the period ended July 31, 2012. The Commission is of the opinion that the public interest and the protection of investors require a suspension of trading in the securities of the above-listed companies. Therefore, it is ordered, pursuant to Section 12(k) of the Securities Exchange Act of 1934, that trading in the securities of the above-listed companies is suspended for the period from 9:30 a.m. EDT on June 17, 2014, through 11:59 p.m. EDT on June 30, 2014. By the Commission. Jill M. Peterson, Assistant Secretary. [FR Doc. 2014–14439 Filed 6–17–14; 4:15 pm] BILLING CODE 8011–01–P 35209 Physical Loan Application Deadline Date: 08/11/2014. Economic Injury (Eidl) Loan Application Deadline Date: 03/11/2015. ADDRESSES: Submit completed loan applications to: U.S. Small Business Administration, Processing and Disbursement Center, 14925 Kingsport Road, Fort Worth, TX 76155. FOR FURTHER INFORMATION CONTACT: A. Escobar, Office of Disaster Assistance, U.S. Small Business Administration, 409 3rd Street SW., Suite 6050, Washington, DC 20416. SUPPLEMENTARY INFORMATION: Notice is hereby given that as a result of the President’s major disaster declaration on 06/11/2014, Private Non-Profit organizations that provide essential services of governmental nature may file disaster loan applications at the address listed above or other locally announced locations. The following areas have been determined to be adversely affected by the disaster: Primary Counties: Caledonia, Essex, Franklin, Lamoille, Orange, Orleans, Washington The Interest Rates are: Percent For Physical Damage: Non-Profit Organizations with Credit Available Elsewhere ... Non-Profit Organizations without Credit Available Elsewhere ..................................... For Economic Injury: Non-Profit Organizations without Credit Available Elsewhere ..................................... 2.625 2.625 2.625 The number assigned to this disaster for physical damage is 14028B and for economic injury is 14029B. (Catalog of Federal Domestic Assistance Numbers 59002 and 59008). U.S. SMALL BUSINESS ADMINISTRATION [Disaster Declaration #14028 and #14029] James E. Rivera, Associate Administrator, for Disaster Assistance. [FR Doc. 2014–14340 Filed 6–18–14; 8:45 am] VERMONT Disaster #VT–00030 BILLING CODE 8025–01–P U.S. Small Business Administration. ACTION: Notice. DEPARTMENT OF STATE AGENCY: [Public Notice 8768] This is a Notice of the Presidential declaration of a major disaster for Public Assistance Only for the State of VERMONT (FEMA–4178– DR), dated 06/11/2014. Incident: Severe Storms and Flooding. Incident Period: 04/15/2014 through 04/18/2014. DATES: Effective Date: 06/11/2014. SUMMARY: PO 00000 Frm 00062 Fmt 4703 Sfmt 4703 60-Day Notice of Proposed Information Collection: Passport Demand Forecasting Study Notice of request for public comment. ACTION: The Department of State is seeking Office of Management and SUMMARY: E:\FR\FM\19JNN1.SGM 19JNN1

Agencies

[Federal Register Volume 79, Number 118 (Thursday, June 19, 2014)]
[Notices]
[Pages 35208-35209]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2014-14438]


-----------------------------------------------------------------------

SECURITIES AND EXCHANGE COMMISSION

[File No. 500-1]


 In the Matter of Applied NeuroSolutions, Inc., Cowlitz 
Bancorporation, First Place Financial Corp., and Kedem Pharmaceuticals, 
Inc.; Order of Suspension of Trading

June 17, 2014.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Applied NeuroSolutions, Inc. because it has not filed any periodic 
reports since the period ended March 31, 2010.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Cowlitz Bancorporation because it has not filed any periodic reports 
since the period ended March 31, 2010.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information

[[Page 35209]]

concerning the securities of First Place Financial Corp. because it has 
not filed any periodic reports since the period ended June 30, 2010.
    It appears to the Securities and Exchange Commission that there is 
a lack of current and accurate information concerning the securities of 
Kedem Pharmaceuticals, Inc. because it failed to include the required 
audited financial statements for the fiscal year ended May 31, 2012 in 
its Form 10-K for the period ended May 31, 2012, and it failed to file 
any periodic reports since it filed a Form 10-Q for the period ended 
November 30, 2012.
    The Commission is of the opinion that the public interest and the 
protection of investors require a suspension of trading in the 
securities of the above-listed companies.
    Therefore, it is ordered, pursuant to Section 12(k) of the 
Securities Exchange Act of 1934, that trading in the securities of the 
above-listed companies is suspended for the period from 9:30 a.m. EDT 
on June 17, 2014, through 11:59 p.m. EDT on June 30, 2014.

    By the Commission.
Jill M. Peterson,
Assistant Secretary.
[FR Doc. 2014-14438 Filed 6-17-14; 4:15 pm]
BILLING CODE 8011-01-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.